<DOC>
	<DOC>NCT01180491</DOC>
	<brief_summary>The purpose of this study is to further evaluate and document early visible effects on nail appearance of topical K101.</brief_summary>
	<brief_title>A Clinical Investigation on Early Visible Effects of Application of K101 During 8 Weeks on Discoloured and Deformed Nails Resulting From Onychomycosis</brief_title>
	<detailed_description />
	<mesh_term>Onychomycosis</mesh_term>
	<criteria>Male or female patients aged 18 years or older 25%75% of the target nail altered as a result of onychomycosis Signed written informed consent Exclusion criteria Proximal subungual onychomycosis Patient who has been previously randomized to treatment in the phase III study K702 investigating K101 Other conditions known to cause abnormal nail appearance Use of topical (1 month before screening) and/or systemic (3 months before screening) antifungal medication. Participation in another clinical study with an investigational drug or device during the previous 4 weeks before enrolment. Known allergy to any of the tested treatment products</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Discoloured and deformed nails resulting from onychomycosis</keyword>
</DOC>